Verisk Analytics, Inc.

VRSK

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

# Signal Note: Eventide Asset Management Initiates VRSK Position **Note:** Verisk Analytics (VRSK) is a data analytics and risk assessment platform company—not a biotech/drug developer.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 48,002Value: $10.7M

# Signal Note: Eventide Asset Management Initiates VRSK Position **Note:** Verisk Analytics (VRSK) is a data analytics and risk assessment platform company—not a biotech/drug developer. This position likely reflects Eventide's allocation toward software/services infrastructure supporting regulated industries (insurance, healthcare) rather than a direct biotech play. The $10.7M stake may indicate conviction in healthcare IT demand drivers, though this sits outside traditional biopharma catalysts and warrants clarification on Eventide's investment thesis.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund NTAP1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: